BriaCell Therapeutics Corp. business relationships

Companies named in BriaCell Therapeutics Corp.’s 10-K filed 2025-10-16, and public companies whose annual reports name BriaCell Therapeutics Corp.. Each link shows the sentence it came from. Scores are Engagemii’s AI visibility scores.

Open on the map Full AI visibility profile

AEO visibility: 5.4 / 10
AI naming: 70 / 100
Agent readiness: 0 / 100
AI adoption: 0 / 100

Named in BriaCell Therapeutics Corp.’s annual report 6

PFIZER INC (PFE)Partner7.7
“Sciences, Inc. and Pfizer, Inc./EMD Serono, Inc. Most of these companies, either alone or together with their collaborative partners,” SEC filing
Merck & Co., Inc. (MRK)Supplier7.7
“as pembrolizumab (KEYTRUDA®; manufactured by Merck & Co., Inc.) and retifanlimab, an immune checkpoint inhibitor manufactured” SEC filing
Roche GroupSupplier7.7
“both manufactured and marketed by Roche/Genentech, may be given to patients with tumors with high expression of HER2 (IHC 3+), as well” SEC filing
INCYTE CORP (INCY)Supplier6.1
“an immune checkpoint inhibitor manufactured by Incyte.” SEC filing
Genentech, IncSupplier4.7
“both manufactured and marketed by Roche/Genentech, may be given to patients with tumors with high expression of HER2 (IHC 3+), as well” SEC filing
Prevail InfoWorks, Inc.Partner4.2
“Collaboration with Prevail InfoWorks, Inc.” SEC filing

Links are read automatically from SEC annual reports (10-K, 20-F, 40-F). In a hand check of random links, about 8 in 10 were real business relationships, so every link carries its source sentence.